Keywords: Cancer vaccines, Market forecasts, Globaldata, Merck & Co, Gardasil, GlaxoSmithKline, Cervarix, Dendreon, Provenge

Cancer vaccines market set to see change, will grow to over $9 billion by 2018

Article | 24 October 2011

Print This

The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and Japan) was worth $3.48 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in